<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Martini R</submitter><funding>National Cancer Institute (NCI)</funding><funding>Susan G. Komen</funding><funding>National Institute on Minority Health and Health Disparities (NIMHD)</funding><funding>U.S. Department of Defense</funding><funding>NIMHD NIH HHS</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institute on Minority Health and Health Disparities</funding><funding>NIGMS NIH HHS</funding><pagination>2530-2551</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9627137</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(11)</volume><pubmed_abstract>Women of sub-Saharan African descent have disproportionately higher incidence of triple-negative breast cancer (TNBC) and TNBC-specific mortality across all populations. Population studies show racial differences in TNBC biology, including higher prevalence of basal-like and quadruple-negative subtypes in African Americans (AA). However, previous investigations relied on self-reported race (SRR) of primarily U.S. populations. Due to heterogeneous genetic admixture and biological consequences of social determinants, the true association of African ancestry with TNBC biology is unclear. To address this, we conducted RNA sequencing on an international cohort of AAs, as well as West and East Africans with TNBC. Using comprehensive genetic ancestry estimation in this African-enriched cohort, we</pubmed_abstract><journal>Cancer discovery</journal><pubmed_title>African Ancestry-Associated Gene Expression Profiles in Triple-Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent.</pubmed_title><pmcid>PMC9627137</pmcid><funding_grant_id>U54 CA233465</funding_grant_id><funding_grant_id>R01 CA259396-01</funding_grant_id><funding_grant_id>R01 CA259396</funding_grant_id><funding_grant_id>U54 MD007585</funding_grant_id><funding_grant_id>P30 CA013148</funding_grant_id><funding_grant_id>U54-MD007585-26</funding_grant_id><funding_grant_id>SC1 GM136521</funding_grant_id><funding_grant_id>L60 MD002419</funding_grant_id><funding_grant_id>P30 CA014089</funding_grant_id><funding_grant_id>U54 CA118623</funding_grant_id><funding_grant_id>U54 CA118948</funding_grant_id><funding_grant_id>PC170315P1</funding_grant_id><funding_grant_id>5U54CA118948</funding_grant_id><funding_grant_id>W81XWH-18-1-0589</funding_grant_id><pubmed_authors>Jibril Suleiman A</pubmed_authors><pubmed_authors>Abebe E</pubmed_authors><pubmed_authors>Bensenhaver JM</pubmed_authors><pubmed_authors>Carpten JD</pubmed_authors><pubmed_authors>Proctor E</pubmed_authors><pubmed_authors>Adjei EK</pubmed_authors><pubmed_authors>White J</pubmed_authors><pubmed_authors>Monojlovic Z</pubmed_authors><pubmed_authors>Mongan N</pubmed_authors><pubmed_authors>Oppong JK</pubmed_authors><pubmed_authors>Awuah B</pubmed_authors><pubmed_authors>Ginter P</pubmed_authors><pubmed_authors>Chu TR</pubmed_authors><pubmed_authors>Muleta MB</pubmed_authors><pubmed_authors>Kyei I</pubmed_authors><pubmed_authors>Aitpillah FS</pubmed_authors><pubmed_authors>Gebregzabher E</pubmed_authors><pubmed_authors>Karanam B</pubmed_authors><pubmed_authors>Verma A</pubmed_authors><pubmed_authors>Bedi D</pubmed_authors><pubmed_authors>Arora K</pubmed_authors><pubmed_authors>Davis MB</pubmed_authors><pubmed_authors>Sboner A</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Ankomah K</pubmed_authors><pubmed_authors>Jackson L</pubmed_authors><pubmed_authors>Osei-Bonsu EB</pubmed_authors><pubmed_authors>Manne U</pubmed_authors><pubmed_authors>Elhussin I</pubmed_authors><pubmed_authors>Adinku MO</pubmed_authors><pubmed_authors>Stonaker B</pubmed_authors><pubmed_authors>Cheng E</pubmed_authors><pubmed_authors>Robine N</pubmed_authors><pubmed_authors>Elemento O</pubmed_authors><pubmed_authors>Petersen LF</pubmed_authors><pubmed_authors>Chitale DA</pubmed_authors><pubmed_authors>Newman L</pubmed_authors><pubmed_authors>Gardner K</pubmed_authors><pubmed_authors>Gibbs LD</pubmed_authors><pubmed_authors>Kittles RA</pubmed_authors><pubmed_authors>Lord B</pubmed_authors><pubmed_authors>Nathanson DS</pubmed_authors><pubmed_authors>Delpe P</pubmed_authors><pubmed_authors>Martini R</pubmed_authors><pubmed_authors>Yates CC</pubmed_authors><pubmed_authors>Gyan KK</pubmed_authors><pubmed_authors>Hoda S</pubmed_authors></additional><is_claimable>false</is_claimable><name>African Ancestry-Associated Gene Expression Profiles in Triple-Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent.</name><description>Women of sub-Saharan African descent have disproportionately higher incidence of triple-negative breast cancer (TNBC) and TNBC-specific mortality across all populations. Population studies show racial differences in TNBC biology, including higher prevalence of basal-like and quadruple-negative subtypes in African Americans (AA). However, previous investigations relied on self-reported race (SRR) of primarily U.S. populations. Due to heterogeneous genetic admixture and biological consequences of social determinants, the true association of African ancestry with TNBC biology is unclear. To address this, we conducted RNA sequencing on an international cohort of AAs, as well as West and East Africans with TNBC. Using comprehensive genetic ancestry estimation in this African-enriched cohort, we</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2026-05-28T03:41:44.614Z</modification><creation>2025-04-04T20:21:45.537Z</creation></dates><accession>S-EPMC9627137</accession><cross_references><pubmed>36121736</pubmed><doi>10.1158/2159-8290.CD-22-0138</doi></cross_references></HashMap>